Intelligence Feed event · Equity · 2026-09-09

    Dentsply Sirona Q2 adjusted EPS of $0.52 beats $0.36 consensus; guidance maintained

    Question

    Dentsply Sirona Q2 adjusted EPS of $0.52 beats $0.36 consensus; guidance maintained

    Direct answer

    Dentsply Sirona posted Q2 adjusted EPS of $0.52, exceeding consensus estimates of $0.36 by $0.16. Although consolidated revenues declined 4.1% year-over-year, the Wellspect Healthcare business delivered 7.1% growth. The company reaffirmed its full-year 2026 outlook, forecasting net sales between $3.5 billion and $3.6 billion and adjusted EPS between $1.40 and $1.50, demonstrating margin stability despite broader dental supply headwinds.

    Original publisher
    Market Ontology
    Evidence through
    2026-09-09
    Published
    2026-10-20
    Revision
    1 · 2026-10-20

    Cite as: Market Ontology, “Dentsply Sirona Q2 adjusted EPS of $0.52 beats $0.36 consensus; guidance maintained”, revision 1, evidence through 2026-09-09. https://marketontology.com/market-events/2026-09-09/dentsply-sirona-q2-adjusted-eps-of-0-52-beats-0-36-consensus-guidance-maintained-0c2ce4

    EQUITY
    Dentsply Sirona Q2 adjusted EPS of $0.52 beats $0.36 consensus; guidance maintained
    Dentsply Sirona posted Q2 adjusted EPS of $0.52, exceeding consensus estimates of $0.36 by $0.16. Although consolidated revenues declined 4.1% year-over-year, the Wellspect Healthcare business delivered 7.1% growth. The company reaffirmed its full-year 2026 outlook, forecasting net sales between $3.5 billion and $3.6 billion and adjusted EPS between $1.40 and $1.50, demonstrating margin stability despite broader dental supply headwinds.
    XRAYALGN
    Impact
    61
    SEP 9
    SIG
    85%
    XRAYALGN
    Dentsply Sirona Q2 adjusted EPS of $0.52 beats $0.36 consensus; guidance maintained
    Dentsply Sirona posted Q2 adjusted EPS of $0.52, exceeding consensus estimates of $0.36 by $0.16. Although consolidated revenues declined 4.1% year-over-year, the Wellspect Healthcare business delivered 7.1% growth. The company reaffirmed its full-year 2026 outlook, forecasting net sales between $3.5 billion and $3.6 billion and adjusted EPS between $1.40 and $1.50, demonstrating margin stability despite broader dental supply headwinds.
    → Operating cost controls and Wellspect revenue resilience offset dental equipment softness to protect XRAY's FY2026 EPS range of $1.40-$1.50.
    Impact
    Dentsply Sirona posted Q2 adjusted EPS of $0.52, exceeding consensus estimates of $0.36 by $0.16. Although consolidated revenues declined 4.1% year-over-year, the Wellspect Healthcare business delivered 7.1% growth. The company reaffirmed its full-year 2026 outlook, forecasting net sales between $3.5 billion and $3.6 billion and adjusted EPS between $1.40 and $1.50, demonstrating margin stability despite broader dental supply headwinds.
    Affected
    XRAYALGN
    Transmission
    Operating cost controls and Wellspect revenue resilience offset dental equipment softness to protect XRAY's FY2026 EPS range of $1.40-$1.50.

    How this development reaches the affected companies

    AssetExposure and channelDirectionEvidence
    XRAYoperating margin preservation lifting adjusted earnings realizationUp1-5dQ2 EPS beat consensus at $0.52 vs $0.36 and FY2026 outlook was reaffirmed.
    ALGNdental device equipment spending read-throughMixed1-5dAlign Technology operates in adjacent dental and orthodontic equipment markets.

    Does this development affect your holdings?

    Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.

    Check this development against my holdings

    Review your initial audit before choosing ongoing portfolio scanning at $79/month.

    What happened next

    AssetCallBase close+1 day+5 days+20 days
    XRAYUpdisagreed10.72 2026-09-09-2.05%-5.41%Pending

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    No verifiable public source recorded for this card.

    Related

    Check this development against my holdings

    See today's live cards

    Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open Desk — $399/month